spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:   EEG 

 HSMN NewsFeed - 4 Jun 2024
Zeto obtains FDA 510(k) clearance for its groundbreaking next-generation EEG brain monitoring product, ONE.
Devices Neurology Monitoring FDA
 HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Devices Endocrinology Regulatory
 HSMN NewsFeed - 21 Mar 2023
U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
Devices Neurology FDA
 HSMN NewsFeed - 23 Sep 2022
iSyncWave EEG Scanner Receives FDA 510k Clearance
Devices Neurology FDA
 HSMN NewsFeed - 14 May 2021
Ceribell Names Diku Mandavia, MD, As Chief Medical Officer
Devices Neurology Monitoring Regulatory
 HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 15 Jan 2021
NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
Devices Neurology Venture Capital
 HSMN NewsFeed - 3 Dec 2020
NeuroOne(R) Medical Technologies Corporation Announces First Human Commercial Use of its Evo(TM) Cortical Electrode at Mayo Clinic
Devices Neurosurgery
 HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Nov 2019
Cadence Neuroscience Secures $15 Million in Series A Financing for Commercialization of Epilepsy Therapy Licensed from Mayo Clinic
Devices Neurology Venture Capital
 HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Sep 2018
Ceribell Announces Completion Of $35 Million Series B Financing
Devices Monitoring Neurology Venture Capital
 HSMN NewsFeed - 29 May 2018
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 15 May 2018
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Devices Neurology Venture Capital
 HSMN NewsFeed - 15 Jun 2017
Magstim Group, Inc. Appoints Lothar Krinke as New CEO
Devices Neurology Personnel
 HSMN NewsFeed - 27 Apr 2017
Moberg Receives $3 Million to Expand Its Focus on Precision Management of Brain Injured Patients
Devices Neurosurgery Monitoring Venture Capital
 HSMN NewsFeed - 10 Mar 2017
Cadwell Launches Arc Synopsis(TM) Trends and Seizure Detection
Devices Monitoring Neurology Product Launch
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 22 Mar 2016
Nihon Kohden Debuts Breakthrough in Neuromonitoring Remote Access with Live View Panel
Devices Monitoring Neurology Product Launch
 HSMN NewsFeed - 11 Feb 2015
Caputron Medical, LLC. Inks Distribution Agreement with Neurosoft LTD
Devices Neurology Distribution
 HSMN NewsFeed - 21 Jul 2014
Zynex Announces Brian Alleman as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 25 Jun 2014
Zynex Appoints Director of Business Development
Devices Personnel
 HSMN NewsFeed - 5 Mar 2014
Intronix Technologies Announces New Canadian Distributor for Myoguide(TM), the Latest Guided Injection System Innovation
Devices Distribution
 HSMN NewsFeed - 7 Jan 2014
Zynex Appoints Vice President of Sales for NeuroDiagnostics Division
Devices Neurology Personnel
 HSMN NewsFeed - 30 Apr 2013
Kevin M. Smith Appointed to Zynex Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 9 Apr 2013
Arrhythmia Research Technology, Inc. Announces New President and Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 30 Aug 2012
Zynex Receives FDA 510(k) Clearance for InWave Medical Device
Devices Urology FDA
 HSMN NewsFeed - 12 Mar 2012
Zynex Acquires NeuroDyne Medical, Corp.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2011
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
Devices Neurology FDA
 HSMN NewsFeed - 31 Aug 2011
Zynex Appoints Vice President of Reimbursement and Billing
Devices Personnel
 HSMN NewsFeed - 24 Aug 2011
Masimo Obtains CE Mark for SEDLine, Launches EEG-Based Brain Function Monitors in European Market
Devices Monitoring
 HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals
 HSMN NewsFeed - 29 Dec 2010
Zynex Strengthens Management Team; Adds Regulatory Compliance Expert
Devices Personnel
 HSMN NewsFeed - 30 Nov 2010
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
Devices Neurology Personnel
 HSMN NewsFeed - 3 Nov 2010
Study in NEJM Shows Novartis Drug Afinitor(R) Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jul 2010
Masimo Acquires SEDLine and Enters the Brain Function Monitoring Market
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2010
CNS Response Announces Thompson Board Resignation
Devices Neurology Personalized Medicine Personnel
 HSMN NewsFeed - 19 Jan 2010
Cyberonics' VNS Therapy(TM) System Receives Regulatory Approval in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2009
Cyberonics Announces Epilepsy Technology Collaborations
Devices Neurology
 HSMN NewsFeed - 14 Sep 2009
Natus Medical to Acquire Alpine Biomed
Devices Monitoring Neurology Mergers & Acquisitions
 HSMN NewsFeed - 1 Jul 2009
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2009
Aircraft Medical Enters Anaesthesia Monitoring Market With Acquisition of Morpheus Medical, S.L.
Devices Acquisitions Monitoring
 HSMN NewsFeed - 17 Apr 2009
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
Devices Neurology
 HSMN NewsFeed - 31 Mar 2009
Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Jan 2009
Astro-Med's Grass Technologies Group Receives FDA Clearance to Market Its Neurotrac(R) III Neuromonitoring System
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 22 Dec 2008
Leading European Universities Choose Elekta to Deliver Advanced 3D Brain Mapping Tool for Research
Devices Neurology
 HSMN NewsFeed - 18 Nov 2008
Nihon Kohden Expands Integration of Masimo SET(R) Pulse Oximetry Technology Worldwide
Devices Monitoring Licensing
 HSMN NewsFeed - 8 Oct 2008
Natus Medical to Acquire Products from BrainZ Instruments Limited
Devices Monitoring Acquisitions
 HSMN NewsFeed - 7 Oct 2008
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2008
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 8 Jul 2008
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
Biopharmaceuticals
 HSMN NewsFeed - 2 Jul 2008
Natus Medical Acquires Schwarzer GmbH Neurology Division
Devices Neurology Acquisitions
 HSMN NewsFeed - 9 Jun 2008
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 23 Apr 2008
FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Mar 2008
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to Froedtert Hospital in Milwaukee
Devices Neurology
 HSMN NewsFeed - 11 Feb 2008
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center
Devices Neurology
 HSMN NewsFeed - 3 Jan 2008
FDA Approves Additional Dosage Strengths of Shire's ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Oct 2007
Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2007
Natus Medical to Acquire Excel-Tech Ltd.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 1 Oct 2007
OBS Medical Announces FDA Clearance of New Patient Safety Technology
Devices Monitoring FDA
 HSMN NewsFeed - 5 Sep 2007
Finland's Nexstim Completes EUR 8 Million Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 4 Sep 2007
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Sep 2007
Shire Voluntarily Withdraws a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 27 Jul 2007
Shire's New ADHD Medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2007
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2007
Aspect Medical Systems Receives FDA Clearance for BIS View(TM) Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 20 Jun 2007
Noven & Shire to Develop New Transdermal Patch For ADHD
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Jun 2007
LinkMed: SACS Medical is Granted FDA Clearance
Devices Monitoring FDA
 HSMN NewsFeed - 19 May 2007
FDA Issues Approvable Letter for SPD465 (Triple-Bead Mixed Amphetamine Salts) for the Treatment of ADHD in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 May 2007
VYVANSE(TM) (lisdexamfetamine dimesylate) Receives Final DEA Schedule Classification, Clearing Way for Launch of First Prodrug Stimulant for Treatment of ADHD
Biopharmaceuticals
 HSMN NewsFeed - 20 Apr 2007
UCB Announces Positive Top-Line Phase III Results for Keppra(R) as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Feb 2007
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to University Clinic in Jena, Germany
Devices Neurology
 HSMN NewsFeed - 21 Dec 2006
Natus Medical Receives FDA Approval for the Olympic Cool-Cap
Devices FDA Neurology
 HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of a Meta-Analysis Comparing Stimulant Medications to Non-Stimulant Medications in Treating ADHD in Patients Aged 8 to 15
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2006
Natus Medical to Acquire Olympic Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2006
Elekta Wins Tender to Deliver Sophisticated 3-D Brain Mapping Technology to Leading German Institution
Devices Neurology
 HSMN NewsFeed - 6 Sep 2006
Natus Medical to Acquire DELTAMED
Devices Mergers & Acquisitions
 HSMN NewsFeed - 19 Jul 2006
Results from Aspect's Cape Cod Memory Study Presented at the International Conference on Alzheimer's Disease and Related Disorders
Devices Neurology
 HSMN NewsFeed - 22 May 2006
Aspect Antidepressant Response Index Accurately Predicts Patient Response to SSRI's after One Week on Medication
Devices
 HSMN NewsFeed - 8 May 2006
Oxford BioSignals Receives FDA Approval for BioSign(TM) Technology
Devices Monitoring FDA
Return to NewsFeed  

 Additional items found! 37

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 37 additional stories matching:
EEG
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.